Pfizer Inc. [NYSE: PFE] disclosed that its board of directors announced a 39-cent third-quarter 2021 dividend on the common stock of the firm, outstanding September 7, 2021, to owners of the Common Stock of record at the close of business on July 30, 2021. The third-quarter 2021 cash dividend will be the 331st successive quarterly dividend paid by Pfizer.
Furthermore, other than the news of the Q3 2021 dividend the stocks of BioNTech, Pfizer, and Moderna, which make the COVID-19 mRNA vaccine, tumbled in the midst of news that the shots could be associated with rare heart inflammation in young people.
Shares of Pfizer plunged 1.41% as the firm has lost -0.56 during the trading session of Wednesday. In the past 52-weeks of the trading session, the share of the firm fluctuated between the 52-week low range of $29.96 and $43.08 from its 52-week high range. Its share went up 30.36% and went down -9.35% from its 52-week low and high, respectively. Pfizer has a total market capitalization of $222.36 billion at the time of writing.
In addition to this, Pfizer disclosed that the Pfizer-BioNTech vaccine is extremely effective against the Delta variant of COVID-19. As per the WHO recommendation, Delta is going to become the internationally leading version of the coronavirus and it was first discovered in India. Moreover, an analysis by Public Health England (PHE), where the Delta variant is more prevalent, discovered that both the Pfizer/BioNTech and AstraZeneca vaccines offer more than 90% protection against hospitalization from the Delta variant.